PMID: 7017062Feb 1, 1981Paper

Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement

The Journal of Experimental Medicine
M A Horwitz, S C Silverstein

Abstract

We have previously reported that virulent egg yolk-grown Legionella pneumophila, Philadelphia 1 strain, multiplies intracellularly in human blood monocytes. We now report on the interaction between virulent L. pneumophila and human polymorphonuclear leukocytes (PMN), antibody, and complement, in vitro, under antibiotic-free conditions. L. pneumophila in concentrations ranging from 10(3) to 10(6) colony forming units (CFU)/ml are completely resistant to the bactericidal effects of 0-50 percent fresh normal human serum, even in the presence of high concentrations of rabbit or human anti-L. pneumophila antibody. L. pneumophila bacteria fix the third component of complement (C3) to their surfaces, as measured by fluorescence microscopy using rhodamine- conjugated goat anti-human C3 IgG, only when the bacteria are incubated with both specific anti-L. pneumophila antibody and complement. Similarly, L. pneumophila adhere to PMN, as measured by fluorescence microscopy, only in the presence of both specific antibody and complement. Electron microscopy revealed that these opsonized bacteria are phagocytosed by the PMN. PMN require both antibody and complement to kill L. pneumophila; even then, PMN reduced CFU of L. pneumophila by only 0....Continue Reading

Citations

Apr 1, 1992·Journal of Bioluminescence and Chemiluminescence·P Rajagopalan-LevasseurJ J Pocidalo
Jan 1, 1994·Biotherapy·T F Byrd
Dec 1, 1987·European Journal of Clinical Microbiology·C RechnitzerL Baek
Jul 14, 1995·Mechanisms of Ageing and Development·H FujioS Yoshida
Mar 1, 1983·Veterinary Immunology and Immunopathology·G S Smith, J H Lumsden
May 16, 1998·Trends in Microbiology·A Casadevall
Jun 24, 2000·Proceedings of the Society for Experimental Biology and Medicine·S L McHughH Friedman
Nov 5, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nicole JollerAnnette Oxenius
Dec 1, 1984·The Journal of Cell Biology·M A Horwitz, F R Maxfield
Nov 1, 1981·The Journal of Experimental Medicine·M A Horwitz, S C Silverstein
Apr 1, 1986·Journal of Interferon Research·P Whitaker DowlingJ S Youngner
Jun 1, 1984·Antimicrobial Agents and Chemotherapy·K VosbeckW Zimmermann
Dec 19, 2000·Infection and Immunity·S L CirilloJ D Cirillo
Apr 22, 2003·Infection and Immunity·Paul H EdelsteinMartha A C Edelstein
Jun 1, 1983·The Journal of Clinical Investigation·M A Horwitz
Jun 1, 1984·The Journal of Clinical Investigation·R F JacobsS J Klebanoff
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·P H EdelsteinS Falkow
Aug 31, 2006·Cellular Microbiology·Constantin F UrbanArturo Zychlinsky
Oct 1, 1986·European Journal of Clinical Investigation·C RechnitzerH Nielsen
Feb 26, 2015·Frontiers in Microbiology·Céline Michard, Patricia Doublet
May 1, 1985·The Journal of Pediatrics·A G PeerlessE R Stiehm
Jan 22, 2004·FEMS Microbiology Letters·Ling Yan, Jeffrey D Cirillo
Nov 15, 2007·European Journal of Immunology·Nicole JollerAnnette Oxenius
Jan 1, 1985·Microbiology and Immunology·T MiyazakiT Watanabe
Jan 1, 1984·Ultrastructural Pathology·S M KatzJ M Hammel
Jan 26, 1989·The New England Journal of Medicine·K GranforsA Toivanen
Oct 1, 1984·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·B Rolstad

❮ Previous
Next ❯